A Behind-The-Counter Class Of Drugs Could Accelerate Rx-To-OTC Switches In U.S.

Without more products accessible without a prescription behind-the-counter, as opposed to off-the-shelf, switches in the U.S. will continue to be limited in number.

Source: Forbes.com Healthcare News - March 2, 2024 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news